Ani Pharmaceuticals Inc (ANIP) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Ani Pharmaceuticals Inc  (NASDAQ: ANIP)
 

Ani Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Ani Pharmaceuticals Inc inventory turnover ratio, the Ani Pharmaceuticals Inc's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 2.87 in the third quarter 2026, ANIP's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Ani Pharmaceuticals Inc in Sep 30 2026 quarter, has decreased to 127 days, compare to 136 days, in the Jun 30 2026 quarter.

Within Healthcare sector 140 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1099 in the second quarter 2026, to 1378.

ANIP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ani Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ANIP Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -6.87 % 3.49 % 4.41 % 4.59 % -1.06 %
Y / Y Cost of Sales Growth 19.43 % 34.23 % 28.13 % 24.9 % 48.06 %
Inventory Turnover Ratio (TTM) 2.87 2.69 2.53 2.42 2.3
ANIP's Total Ranking # 1378 # 1099 # 1011 # 914 #
Average inventory processing period 127 136 144 151 159
Seq. Inventory Growth -4.71 % -0.22 % 0.28 % -2.33 % 5.9 %
Seq. Cost of Sales Growth 11.36 % 7.03 % -6.67 % 7.37 % 25.16 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 34
Healthcare Sector # 141
Overall Market # 1378

Inventory Turnover Ratio Statistics
High Average Low
3.6 1.79 0.99
(Mar 31 2014)   (Mar 31 2016)



ANIP Company Profile >> Back to ANIP Efficiency Comparisons >> Compare ANIP Inventory Turnover Ratio to its Competitors

Financial Statements
Ani Pharmaceuticals Inc's Inventories $ 136 Millions Visit ANIP's Balance sheet
Ani Pharmaceuticals Inc's Cost of Revenues TTM $ 406 Millions Visit ANIP's Income Statement
What are ANIP's Sales? Visit ANIP's Sales by Segment

Other Inventory Turnover Ratios
Ani Pharmaceuticals Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ANIP's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ANIP's Competitors
Inventory Turnover Ratio for ANIP's Suppliers
Inventory Turnover Ratio for ANIP's Customers

You may also want to know
ANIP's Sales Growth Rates ANIP's Pe Price to earnings ratio ANIP's Receivables Turnover Ratio ANIP's Stock Quote
ANIP's Net Income Growth Rates ANIP's Ps Price to Sales ratio ANIP's Sales per Employee ANIP's Asset Turnover Ratio
ANIP's Net Margin ANIP's Pb Price to Book ratio ANIP's Financial Strength Ratios ANIP's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions

Date modified: 2026-11-09T06:44:24+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.